Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Boiron SA (FR:BOI)
PARIS:BOI
Boiron SA (BOI) Stock Price & Analysis
4 Followers
BOI Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€29.30 - €43.65
Previous Close€32.6
Volume197.00
Average Volume (3M)2.57K
Market Cap
€571.11M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)15.8
Beta-0.20
Next Earnings
Sep 04, 2024EPS EstimateN/A
Last Dividend Ex-Date
Jun 03, 2024Dividend Yield4.29%
Share Statistics
EPS (TTM)2.06
Shares Outstanding17,361,683
10 Day Avg. Volume4,064
30 Day Avg. Volume2,573
Standard Deviation0.09
R-Squared0.03
Alpha0.00571
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.92% Mutual Funds
0.33% Other Institutional Investors
98.75% Public Companies and
Individual Investors
BOI FAQ
What was Boiron SA’s price range in the past 12 months?
Boiron SA lowest stock price was €29.30 and its highest was €43.65 in the past 12 months.
What is Boiron SA’s market cap?
Currently, no data Available
When is Boiron SA’s upcoming earnings report date?
Boiron SA’s upcoming earnings report date is Sep 04, 2024 which is in 44 days.
How were Boiron SA’s earnings last quarter?
Boiron SA released its earnings results on Feb 04, 2024. The company reported €1.173 earnings per share for the quarter, beating the consensus estimate of N/A by €1.173.
Is Boiron SA overvalued?
According to Wall Street analysts Boiron SA’s price is currently Overvalued.
Does Boiron SA pay dividends?
Boiron SA pays a Annually dividend of €1.35 which represents an annual dividend yield of 4.29%. See more information on Boiron SA dividends here
What is Boiron SA’s EPS estimate?
Boiron SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Boiron SA have?
Boiron SA has 17,545,408 shares outstanding.
What happened to Boiron SA’s price movement after its last earnings report?
Boiron SA reported an EPS of €1.173 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.535%.
Which hedge fund is a major shareholder of Boiron SA?
Currently, no hedge funds are holding shares in FR:BOI
---
Boiron SA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.56%
12-Months-Change
Fundamentals
Return on Equity
7.53%
Trailing 12-Months
Asset Growth
-25.24%
Trailing 12-Months
Company Description
Boiron SA
Boiron is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.
---
Technical Analysis
---